Latest Stock Split Details
Key information about Regulus Therapeutics Inc.'s most recent stock split
Split Date: 2022-06-29
Split Ratio: 1:10
Price Before Split: $0.21
Price After Split: $0.02
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 10.00 times fewer shares (a 1:10 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of Regulus Therapeutics Inc.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2022-06-29 | 1:10 | Yes | $0.21 | $0.02 |
| 2018-10-04 | 1:12 | Yes | $0.19 | $0.02 |
About Regulus Therapeutics Inc.
Company overview and industry information
Regulus Therapeutics Inc. (RGLS) operates in the Biotechnology industry. The recent 1-for-10 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.
Biotechnology
Go to Regulus Therapeutics Inc. Summary